Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
2(14%)
Results Posted
17%(1 trials)
Terminated
1(7%)

Phase Distribution

Ph not_applicable
1
7%
Ph phase_3
5
36%
Ph phase_4
5
36%
Ph phase_2
1
7%

Phase Distribution

0

Early Stage

1

Mid Stage

10

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
5(41.7%)
Phase 4Post-market surveillance
5(41.7%)
N/ANon-phased studies
1(8.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

14

all time

Status Distribution
Active(3)
Completed(6)
Terminated(1)
Other(4)

Detailed Status

Completed6
unknown4
Recruiting2
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
2
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (8.3%)
Phase 35 (41.7%)
Phase 45 (41.7%)
N/A1 (8.3%)

Trials by Status

terminated17%
recruiting214%
completed643%
unknown429%
not_yet_recruiting17%

Recent Activity

2 active trials
Showing 5 of 14
recruitingphase_3

Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The PLICTS Study

NCT04067505
recruitingphase_3

Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters

NCT04066764
not_yet_recruitingnot_applicable

Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT

NCT06319131
completed

Nadroparin Pharmacokinetics in Different Stages of COVID-19

NCT05621915
completedphase_3

Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery

NCT01431456
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT04067505Phase 3

Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The PLICTS Study

Recruiting
NCT04066764Phase 3

Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters

Recruiting
NCT06319131Not Applicable

Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT

Not Yet Recruiting
NCT05621915

Nadroparin Pharmacokinetics in Different Stages of COVID-19

Completed
NCT01431456Phase 3

Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery

Completed
NCT00312013Phase 3

Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer

Completed
NCT02957877Phase 4

LMWH Infusion as Anticoagulation for Home HD

Unknown
NCT00843492Phase 3

A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery

Completed
NCT02295150Phase 4

Prophylaxis of Venous Thromboembolism After Bariatric Surgery

Unknown
NCT01862978Phase 4

Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke

Unknown
NCT00881088Phase 2

Prophylaxis of Thromboembolic Complications Trial: Thromboprophylaxis Needed in Below Knee Plaster Cast Immobilization for Ankle and Foot Fractures

Unknown
NCT00286273Phase 4

Safety and Efficacy of the Use of Regional Anticoagulation With Citrate in Continuous Venovenous Hemofiltration

Completed
NCT00796692Phase 4

Nadroparin for the Initial Treatment of Pulmonary Thromboembolism

Completed
NCT00303407

Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care

Terminated

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14